Patrick Amstutz
Founder presso MOLECULAR PARTNERS AG
Patrimonio netto: 3 M $ in data 31/03/2024
Posizioni attive di Patrick Amstutz
Società | Posizione | Inizio | Fine |
---|---|---|---|
MOLECULAR PARTNERS AG | Director/Board Member | 12/05/2017 | - |
Chief Executive Officer | 07/11/2016 | - | |
Founder | 23/11/2004 | - | |
Chief Operating Officer | 23/11/2004 | 12/05/2017 | |
Corporate Officer/Principal | 23/11/2004 | 23/11/2004 | |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | President | 03/05/2022 | - |
Corporate Officer/Principal | 01/01/2017 | 03/05/2022 | |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Director/Board Member | - | - |
Chief Executive Officer | - | - |
Storia della carriera di Patrick Amstutz
Formazione di Patrick Amstutz
University of Zurich | Doctorate Degree |
Swiss Federal Institute of Technology | Graduate Degree |
Statistiche
Distribuzione geografica
Svizzera | 4 |
Germania | 2 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Settori
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MOLECULAR PARTNERS AG | Health Technology |
Aziende private | 2 |
---|---|
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Commercial Services |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |
- Borsa valori
- Insiders
- Patrick Amstutz
- Esperienza